Whiplash hits geopolitical headwinds as a back-and-forth in U.S. and Iran talks fluctuate the price action in futures. Tom White explains why investors should take headlines out of Iran "with a grain of salt" as peace talks to fully reopen the Strait of Hormuz continue. In equities, Tom talks about the price target hikes in AI semiconductor equipment makers and AbbVie's (ABBV) $10.9 billion acquisition of Apogee Therapeutics (APGE). He also touches on reports of SpaceX (SPCX) preparing a $20 billion offering.